Their melanin nanoparticles, which exhibit strong photothermal activation with NIR light, were then coated with cancer cell membranes to aid in trafficking to the tumor site and loaded with indoleamine 2,3-dioxygenase (IDO) inhibitors to overcome the immunosuppressive effects of the tumor microenvironment. The gene discussed is IDO2; the disease is neoplasm.